We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Jan 2022 17:37

RNS Number : 8381X
Midatech Pharma PLC
07 January 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BKT14T00

Issuer Name

MIDATECH PHARMA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Cantor Fitzgerald Europe

City of registered office (if applicable)

 

Country of registered office (if applicable)

GB

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

06-Jan-2022

6. Date on which Issuer notified

07-Jan-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.200968

0.000000

5.200968

5121309

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BKT14T00

5121309

5.200968

Sub Total 8.A

5121309

5.200968%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

 

13. Place Of Completion

UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLBRMRTMTJMBIT
Date   Source Headline
9th Jun 20208:24 amRNSForm 8.3 - Midatech Pharma plc
9th Jun 20208:10 amRNSForm 8.3 - Midatech Pharma plc
8th Jun 20207:00 amRNSResearch collaboration with Dr Reddy’s
1st Jun 202011:26 amRNSForm 8.3 - Midatech
29th May 202012:24 pmRNSForm 8.3 - Midatech Pharma plc
29th May 20209:59 amRNSHolding(s) in Company
28th May 20204:22 pmRNSForm 8.3 - Midatech Pharma Plc (Amended)
28th May 20204:00 pmRNSForm 8.3 - Midatech Pharma plc
28th May 20203:51 pmRNSForm 8.3 - [Midatech Pharma Plc]
28th May 20207:00 amRNSForm 8.3 - Midatech Pharma Plc
28th May 20207:00 amRNSForm 8.3 - Midatech Pharma Plc
27th May 20205:59 pmRNSForm 8.3 - Midatech Pharma PLC
27th May 20207:00 amRNSForm 8.3 - [Midatech Pharma plc]
26th May 20209:16 amRNSForm 8.3 - Midatech Pharma PLC
22nd May 20204:02 pmRNSForm 8.3 - Midatech Pharma plc
22nd May 20209:56 amRNSRule 2.9 Announcement
21st May 20207:01 amRNSRule 2.9 Announcement
21st May 20207:00 amRNSClosing of US$3.0m Registered Direct Offering
20th May 202011:36 amRNSForm 8.5 (EPT/RI)
19th May 202011:10 amRNSCorrection: UK Placing to Raise £1.8 million
18th May 20202:43 pmRNSUK Placing to Raise £1.8 million
18th May 20202:08 pmRNSUS$3.0 Million Registered Direct Offering
18th May 20207:00 amRNSHeadline Results for the Year Ended 31 Dec 2019
13th May 202011:28 amRNSForm 8.5 (EPT/RI)
12th May 20205:17 pmRNSAmendment to Relationship Agreement
5th May 202010:54 amRNSForm 8.3 - Midatech Pharma plc
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
4th May 202011:28 amRNSForm 8.5 (EPT/RI)
4th May 20207:00 amRNSForm 8 (OPD) (Midatech Pharma plc)
1st May 202011:08 amRNSStatement regarding Price Movement
30th Apr 20204:42 pmRNSSecond Price Monitoring Extn
30th Apr 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20208:56 amEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc Replacement
22nd Apr 20203:51 pmRNSRule 2.9 Announcement - Typo Correction
22nd Apr 202012:00 pmRNSForm 8.3 - Midatech Pharma Plc - Replacement
22nd Apr 202011:43 amEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc
21st Apr 20203:20 pmRNSForm 8.3 - Midatech Pharma plc
20th Apr 20205:22 pmRNSRule 2.9 Announcement
20th Apr 20207:00 amRNSStrategic Review Update, Formal Sale Process
31st Mar 20207:00 amRNSStrategic Review, Update and Directorate Changes
2nd Mar 20203:48 pmRNSResult of General Meeting
2nd Mar 20207:00 amRNSMidatech Expands MTX110 DIPG Programme
13th Feb 20202:05 pmRNSSecond Price Monitoring Extn
13th Feb 20202:00 pmRNSPrice Monitoring Extension
12th Feb 20202:13 pmRNSNotice of General Meeting
8th Jan 20204:41 pmRNSSecond Price Monitoring Extn
8th Jan 20204:35 pmRNSPrice Monitoring Extension
8th Jan 20207:00 amRNSPositive Results from MTD201-102 Study
16th Dec 20197:00 amRNSReceipt of NASDAQ Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.